Cargando…
Preferential Cochleotoxicity of Cisplatin
Cisplatin-induced ototoxicity in humans is more predominant in the cochlea than in the vestibule. Neither definite nor substantial vestibular dysfunction after cisplatin treatment has been consistently reported in the current literature. Inner ear hair cells seem to have intrinsic characteristics th...
Autores principales: | Prayuenyong, Pattarawadee, Baguley, David M., Kros, Corné J., Steyger, Peter S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350121/ https://www.ncbi.nlm.nih.gov/pubmed/34381329 http://dx.doi.org/10.3389/fnins.2021.695268 |
Ejemplares similares
-
Aminoglycoside-Induced Cochleotoxicity: A Review
por: Jiang, Meiyan, et al.
Publicado: (2017) -
Potential Mechanisms Underlying Inflammation-Enhanced Aminoglycoside-Induced Cochleotoxicity
por: Jiang, Meiyan, et al.
Publicado: (2017) -
Audiovestibular clinician experiences and opinions about cisplatin vestibulotoxicity
por: Prayuenyong, Pattarawadee, et al.
Publicado: (2020) -
Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy
por: Baguley, David M., et al.
Publicado: (2019) -
Development of Tinnitus and Hyperacusis in a Mouse Model of Tobramycin Cochleotoxicity
por: Longenecker, Ryan J., et al.
Publicado: (2021)